ETERNITY HEALTHCARE INC. (OTCMKTS:ETAH) Files An 8-K Entry into a Material Definitive Agreement

ETERNITY HEALTHCARE INC. (OTCMKTS:ETAH) Files An 8-K Entry into a Material Definitive Agreement
Item 9.01 Entry Into a Material Definitive Agreement

Story continues below

On December 13, 2017, Eternity Healthcare Inc. (the “Company”) entered into a Share Exchange Agreement with the equity holders of Guizho Tongren Healthy China Biotechnology Co. Ltd., a company recently formed to engage in the business of providing stem cell storage and related medical therapies in China. to the Agreement, in exchange for all of the outstanding equity in Guizho Tongren Healthy China Biotechnology Co. Ltd., the Company will issue to its current owners 17,181,769 shares of the Company’s common stock.

Item 9.01 Regulation FD Disclosure

On December 15, 2017, the Company issued a press release announcing the entry into a Share Exchange Agreement with the shareholders of Guizho Tongren Healthy China Biotechnology Co. Ltd. A copy of the press release is filed as Exhibit 99.1 to this report.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.


ETERNITY HEALTHCARE INC. Exhibit
EX-99.1 2 f8k121317ex99-1_eternity.htm TEXT OF PRESS RELEASE ISSUED BY ETERNITY HEALTHCARE INC. Exhibit 99.1   Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.   NEW YORK,…
To view the full exhibit click here

About ETERNITY HEALTHCARE INC. (OTCMKTS:ETAH)

Eternity Healthcare Inc. is a medical device company. The Company is engaged in the discovery, development and marketing of medical devices. The Company is focused on marketing of its needle-free injection device technology. It also includes an over the counter pain treatment device using laser as treatment source. Its products include Nozzles/syringes, Adapters, Nozzle/Adapter Combination Pack and Adapters (Large). The Company’s products are sold to healthcare professionals for use in physicians’ offices, pharmacies and to all consumers. It provides delivery technologies for insulin, human chorionic gonadotropin (hCG), human growth hormone (hGH), Vitamin B12, vaccines, anesthetics, migraine medication and steroids. The Company provides a soft injection system that avoids the use of needles for the delivery of various sorts of injectable medications, including cancer medication. It is a universal injection system that can deliver medication in both pediatrics and adults.

An ad to help with our costs